No attachments available.
NOTICE OF INTENT TO SOLE SOURCE - Chronic Kidney Disease Epidemiology in the Military Health System
Contact and place of performance
Ann Bonis
MD 20817
USA
The Centers for Disease Control and Prevention (CDC) intends to award a sole source Firm-Fixed-Price contract to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), 6720-A Rockledge Drive, Bethesda, MD 20817, for Chronic Kidney Disease Epidemiology in the Military Health System. The proposed contract will provide continued support for CDC’s Chronic Kidney Disease (CKD) surveill...
View moreThe anticipated period of performance is June 14, 2026 through June 13, 2030, consisting of a one-year base period and three one-year option periods.
This notice of intent is not a request for competitive proposals; however, all capability statements, proposals, or quotations received within fifteen (15) calendar days after publication of this notice shall be considered by the Government. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.
All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.
Responses shall be submitted electronically to the assigned CDC Contract Specialist identified in the SAM.gov notice by the date and time specified in the posting.
The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm-fixed-price contract to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) to support Chronic Kidney Disease (CKD) surveillance and epidemiology activities. This requirement involves the establishment and maintenance of an analytical database used to assess the diagnosis, treatment, complications, and outcomes of CKD within the Military Health System (MHS). The contractor will perform epidemiologic analyses of CKD and end-stage kidney disease, evaluate risk factors and disease patterns among active-duty and non-active-duty populations, and investigate rare causes of CKD as well as pediatric cases.
The proposed contract action, identified under solicitation number 75D30126R73461, is being conducted pursuant to FAR 6.302-1 as HJF is the only source with the necessary access and capabilities to support the requirement without substantial duplication of cost or unacceptable delays. No set-aside is assigned for this procurement. The anticipated period of performance runs from June 14, 2026, through June 13, 2030, which includes a one-year base period and three one-year option periods. Primary performance will take place in Maryland.
While this notice is not a request for competitive proposals, the government will consider capability statements, proposals, or quotations received by the response deadline of June 18, 2026. Submissions must be sent electronically to the designated point of contact, Ann Bonis. Information received from responsible sources will be used by the CDC to determine whether a competitive procurement should be conducted. This special notice was published on June 3, 2026, and contains no attachments.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.